Florida Wellness Clinic Regulation in 2026: The Stem Cell Law, the Med Spa Bills That Died, and What Comes Back

Florida is one of the largest wellness markets in the country, and clinic owners often assume that means a heavily regulated one. In fact, Florida enacted very little in 2025 and 2026 aimed at med spas. What it did enact, the stem cell law, is important to the clinics it touches. What it considered and rejected is a preview of what regulators want.

The Stem Cell Therapy Law (SB 1768)

Signed June 25, 2025 and effective July 1, 2025, SB 1768 creates new sections of the medical and osteopathic practice acts. As we read the enrolled text, it works like this.

• Who and what: it applies to MD and DO physicians and allows use of stem cell therapies that are not FDA-approved only for orthopedic, wound care or pain management purposes, within the physician's scope. The text does not mention PAs or APRNs.
• Sourcing: cells must come from an FDA-registered facility accredited by recognized bodies and following current good manufacturing practice, with a post-thaw viability report for each lot and contract terms requiring notice of status changes.
• Consent: written, signed consent that states the therapy is not FDA-approved.
• Advertising: ads must carry a prescribed notice beginning "THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW," legible and in type no smaller than the largest type in the ad.
• Penalties: violations bring board discipline. Using fetal or embryonic cells obtained after abortion is a third-degree felony.
• Exemptions: physicians holding an FDA investigational authorization, and those working under contract for certain accredited institutions, are exempt.

A Copy of the Model for Podiatry

In 2026, SB 1092 (effective June 11, 2026) extended a similar framework to certain podiatrists, with written notice, consent and an advertising disclaimer. It appears to copy the stem cell law's model, which suggests Florida's approach to non-FDA-approved cellular products will keep spreading by profession. We did not read the enrolled text, so check it before relying on details.

The Bills That Died

• Med spa licensure (SB 1728 and HB 1429): the "Medical Spa Prescription Drug Oversight Act" would have required med spa registration starting July 1, 2026, a responsible practitioner, a public database, Board of Pharmacy oversight, inspections and adverse-incident reporting. It died March 13, 2026. It signals that the Board of Pharmacy is a plausible future regulator.
• Compounded weight-loss drugs (SB 860 and HB 877): would have required documentation before selling compounded weight-loss medication, recordkeeping and an advertising prohibition. Both died in committee in March 2026.
• APRN and CRNA autonomy: bills that would have expanded independent practice died in 2025 and 2026. Florida's 2020 primary care autonomous practice law is unchanged.
• Naturopathic licensure (SB 688): vetoed June 26, 2026.

Corporate Practice and Management Deals

Florida has no codified corporate practice of medicine doctrine for physicians, which is why a non-physician can own a clinic more freely than in a state like Texas or California. That does not mean there are no constraints on MSO and ownership arrangements. Practitioner commentary points to the Health Care Clinic Act and its exemption rules, the physician fee-splitting statute and change-of-ownership filings. We read those cites only as relayed by a trade publication, so have Florida counsel confirm how they apply to your deal. We found no 2026 Florida CPOM bill.

Office Surgery Rules

The Board of Medicine amended its office surgery registration rule, effective March 2, 2026, revising the registration application and clarifying when the Board may take discipline alongside a corrective action plan. It affects physicians performing Level II and III office surgery and large-volume liposuction. Florida's 2023 law on office surgery and Brazilian butt lift procedures remains the main statute here.

Federal Items That Drive Florida Practice

• GLP-1 compounding: FDA resolved the tirzepatide and semaglutide shortages, ended the related compounding enforcement discretion in 2025, and in February 2026 said it intends to restrict GLP-1 active ingredients in mass-marketed compounded drugs. It sent about 30 warning letters to telehealth firms in March 2026 and, per reports, about 25 more in June. A proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list was not final when we checked.
• Peptides: an FDA advisory committee voted 8 to 6 in July 2026 to recommend BPC-157 for the 503A bulks list. It is advisory only. We found no Florida peptide law.
• Hormone therapy: FDA began removing boxed warnings from menopausal hormone therapy labels in November 2025 and approved label changes for several products in February 2026.
• Telemedicine: DEA flexibilities for controlled substances run through December 31, 2026. Florida's telehealth statute was not amended after 2023, as far as we could confirm.

Enforcement

Local press and trade sources report continued arrests for unlicensed Botox and cosmetic procedures in South Florida and elsewhere. We could not find state statistics, so treat claims that Florida leads the country in unlicensed procedures as unverified.

What a Florida Clinic Should Do

• If you offer stem cell therapy, confirm the physician, the sourcing, the consent form and the advertising notice against SB 1768.
• Treat the failed med spa bills as a preview. Document who your responsible physician is, how drugs are stored and ordered, and how adverse events are handled.
• Review marketing claims for compounded GLP-1 products against FDA's statements about "same as" and "clinically proven" claims.
• Have Florida counsel review any management or ownership deal against the clinic act, fee-splitting and change-of-ownership rules.
• Plan for the December 31, 2026 telemedicine deadline if you prescribe testosterone remotely.

Where MedGrid Fits

Florida's flexibility is real, but a clinic still needs a physician's real protocols, delegation and oversight, and the more freedom a state gives, the more it falls to the clinic to document its own structure. MedGrid connects Florida clinics with a Florida-licensed physician, builds protocols and standing orders, and helps owners decide whether to keep the separation of a physician-owned entity and a management company even where the state does not require it. That is a business and liability decision as much as a legal one, and it matters when you want financing or a sale.

Frequently Asked Questions

• Is stem cell therapy legal in Florida now?: Under SB 1768, certain non-FDA-approved stem cell therapies may be used by MD and DO physicians for orthopedic, wound care and pain management purposes if sourcing, consent and advertising requirements are met.
• Does Florida license med spas?: No. Bills to do so died in March 2026, and a med spa registration bill is likely to return.
• Does Florida enforce corporate practice of medicine?: There is no codified CPOM doctrine for physicians, but other rules shape how management arrangements are built.
• Can NPs practice independently in Florida?: Florida's 2020 law allows autonomous practice in primary care for qualifying APRNs. Bills to expand autonomy failed in 2025 and 2026.
• Are compounded GLP-1s legal in Florida?: The shortage-based compounding discretion ended in 2025, and federal enforcement is increasing. A compounded product needs a documented patient-specific reason and a lawful pharmacy setup.

This article is general educational information, not legal advice. It reflects statute pages, rule pages and law-firm summaries as of the publication date, and some items could not be confirmed against primary text. Confirm your obligations with the relevant Florida boards and licensed Florida healthcare counsel.